Free Trial

North American Data Eyed

SNAPSHOT

Below gives key levels of markets in the second half of the Asia-Pac session:

  • Nikkei 225 up 208.82 points at 28770.71
  • ASX 200 up 22.834 points at 7387.6
  • Shanghai Comp. up 3.135 points at 3625.753
  • JGB 10-Yr future down 3 ticks at 151.87, yield down 0bp at 0.061%
  • Aussie 10-Yr future down 0.5 tick at 98.355, yield up 0.7bp at 1.591%
  • U.S. 10-Yr future up 0-00+ at 130-24, yield up 0.51bp at 1.4566%
  • WTI crude up $0.21 at $72.97, Gold up $2.53 at $1806.2
  • USD/JPY up 8 pips at Y114.18
  • OMICRON HOSPITALIZATION RISK BELOW DELTA’S IN EARLY STUDIES (BBG)
  • FDA AUTHORIZES PFIZER’S COVID TREATMENT PILL, THE FIRST ORAL ANTIVIRAL DRUG CLEARED DURING THE PANDEMIC (CNBC)
  • DUP TO PRESSURE LIZ TRUSS TO TRIGGER 'NUCLEAR OPTION' IN BREXIT NEGOTIATIONS (TELEGRAPH)
  • PBOC TO MAINTAIN AMPLE LIQUIDITY THROUGH EARLY 2022 (CSJ)
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.